Key Highlights

  • FRST is trading down 0.57% at $15.58 on October 21, with a market capitalization of about $386.37 million.
  • Third-quarter results are due after the close on Thursday, October 22, with a call on Friday, October 23 at 10:00 a.m. ET.
  • Second-quarter EPS was $0.38, against $0.10 a year earlier and $0.30 in the first quarter.
  • The second-quarter net interest margin was 3.45%, up from 2.86% a year earlier.
  • Management expects the margin to stay within about 1 to 2 basis points of current levels.

Are Investors Overlooking the One-Off Gains Behind Primis Financial's Earnings Setup?

Primis Financial (NASDAQ:FRST) is trading down 0.57% at $15.58 on October 21, and no company announcement was identified for the session. The company has confirmed that it will report third-quarter results after the close on Thursday, October 22, with a call on Friday, October 23 at 10:00 a.m. ET.

What investors may be overlooking is how much of the recent improvement came from non-recurring items. The second quarter included a $5.9 million gain on the sale of an insurance agency investment, partly offset by a legal settlement and a reserve build. The reported EPS jump therefore needs to be read alongside what the underlying bank earned, and management described the 0.90% return on assets as representative of its recurring level.

Primis is the holding company for Primis Bank in Virginia, which offers community banking and commercial services.

What Did the Second-Quarter Results and Call Set Up?

In the second quarter, reported July 23, EPS was $0.38 against $0.10 a year earlier, and net income to common was $9.4 million. Net interest income was $33.8 million, up 34% year over year, and the net interest margin was 3.45%, up 59 basis points from a year earlier. Noninterest income was $22.0 million, including $11.4 million from mortgage activity, which rose 44%.

Loans held for investment grew about 8% annualized from the first quarter. Nonperforming assets fell 37% to $63 million, though the provision rose to $5.5 million, of which $5.3 million was a specific reserve on the largest office loan, now on nonaccrual. The shares fell 2.23% after the report.

Management's outlook was specific. The margin is expected to stay within about 1 to 2 basis points of current levels as loan pricing stays competitive, and a subordinated debt refinancing within one to two quarters could cut that debt's cost by 200 to 250 basis points. Third-quarter noninterest expense excluding mortgage and Panacea volatility is guided back to $22.0 million to $22.5 million.

Why Are the Trailing EPS and P/E Figures Distorted?

Trailing EPS of $2.15, trailing EPS growth of 1,691.17% and the P/E of 7.25 are affected by one-time items and prior-year losses, and they are not a clean guide to earnings power. Full-year 2025 non-GAAP EPS was $0.39 while net income was $61.4 million, which points to large gains in that year.

The dividend is $0.10 a quarter and the yield is 2.55%. The consensus analyst rating is Strong Buy.

What Would a Good or Bad Reading Look Like on October 22?

An encouraging report would show a margin holding near 3.45%, nonperforming assets continuing to fall, expenses back near $22 million to $22.5 million and no new large reserve builds. Management also expects the core conversion to add about $6.1 million of annual earnings improvement, mostly from early 2027.

A concerning report would show a margin reversal, a further office credit charge or earnings that again depend on one-time gains. Because the second quarter was flattered by the $5.9 million gain, investors will focus on the quality of earnings and not just the headline EPS.